tiprankstipranks
Z Squared (ZSQR)
NASDAQ:ZSQR
US Market
Want to see ZSQR full AI Analyst Report?

Z Squared (ZSQR) Price & Analysis

141 Followers

ZSQR Stock Chart & Stats

$14.65
$0.24(3.56%)
At close: 4:00 PM EST
$14.65
$0.24(3.56%)

ZSQR FAQ

What was Z Squared’s price range in the past 12 months?
Z Squared lowest stock price was $6.80 and its highest was $21.41 in the past 12 months.
    What is Z Squared’s market cap?
    Z Squared’s market cap is $445.91M.
      When is Z Squared’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Z Squared’s earnings last quarter?
      Currently, no data Available
      Is Z Squared overvalued?
      According to Wall Street analysts Z Squared’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Z Squared pay dividends?
        Z Squared does not currently pay dividends.
        What is Z Squared’s EPS estimate?
        Z Squared’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Z Squared have?
        Z Squared has 51,431,490 shares outstanding.
          What happened to Z Squared’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Z Squared?
          Currently, no hedge funds are holding shares in ZSQR
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Z Squared Stock Smart Score

            Company Description

            Z Squared

            Operates as a digital asset mining company
            Similar Stocks
            Company
            Price & Change
            Follow
            Relmada Therapeutics
            ABVC BioPharma
            Prelude Therapeutics
            Werewolf Therapeutics
            Estrella Immunopharma

            Ownership Overview

            1.77%0.68%96.92%
            ― Other Institutional Investors
            96.92% Public Companies and
            Individual Investors

            Options Prices

            Currently, No data available
            ---
            Popular Stocks